ZimVie (ZIMV) Competitors $9.54 -0.28 (-2.85%) As of 10:08 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZIMV vs. BLFS, KMTS, MDXG, ESTA, FNA, EYE, AORT, RXST, PLSE, and AXGNShould you be buying ZimVie stock or one of its competitors? The main competitors of ZimVie include BioLife Solutions (BLFS), Kestra Medical Technologies (KMTS), MiMedx Group (MDXG), Establishment Labs (ESTA), Paragon 28 (FNA), National Vision (EYE), Artivion (AORT), RxSight (RXST), Pulse Biosciences (PLSE), and AxoGen (AXGN). These companies are all part of the "medical equipment" industry. ZimVie vs. BioLife Solutions Kestra Medical Technologies MiMedx Group Establishment Labs Paragon 28 National Vision Artivion RxSight Pulse Biosciences AxoGen BioLife Solutions (NASDAQ:BLFS) and ZimVie (NASDAQ:ZIMV) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, community ranking, media sentiment, risk, profitability and institutional ownership. Does the MarketBeat Community favor BLFS or ZIMV? BioLife Solutions received 308 more outperform votes than ZimVie when rated by MarketBeat users. Likewise, 67.24% of users gave BioLife Solutions an outperform vote while only 22.22% of users gave ZimVie an outperform vote. CompanyUnderperformOutperformBioLife SolutionsOutperform Votes31267.24% Underperform Votes15232.76% ZimVieOutperform Votes422.22% Underperform Votes1477.78% Do insiders & institutionals have more ownership in BLFS or ZIMV? 93.2% of BioLife Solutions shares are held by institutional investors. Comparatively, 95.6% of ZimVie shares are held by institutional investors. 2.2% of BioLife Solutions shares are held by company insiders. Comparatively, 3.0% of ZimVie shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is BLFS or ZIMV more profitable? BioLife Solutions has a net margin of -38.98% compared to ZimVie's net margin of -77.31%. ZimVie's return on equity of 2.90% beat BioLife Solutions' return on equity.Company Net Margins Return on Equity Return on Assets BioLife Solutions-38.98% -6.61% -5.54% ZimVie -77.31%2.90%1.17% Which has higher earnings and valuation, BLFS or ZIMV? BioLife Solutions has higher earnings, but lower revenue than ZimVie. BioLife Solutions is trading at a lower price-to-earnings ratio than ZimVie, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioLife Solutions$82.25M12.82-$66.43M-$0.50-44.88ZimVie$449.75M0.61-$393.28M-$0.95-10.34 Do analysts rate BLFS or ZIMV? BioLife Solutions currently has a consensus price target of $31.17, suggesting a potential upside of 38.89%. ZimVie has a consensus price target of $23.00, suggesting a potential upside of 134.22%. Given ZimVie's higher possible upside, analysts plainly believe ZimVie is more favorable than BioLife Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLife Solutions 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00ZimVie 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more risk and volatility, BLFS or ZIMV? BioLife Solutions has a beta of 2.04, indicating that its stock price is 104% more volatile than the S&P 500. Comparatively, ZimVie has a beta of 2.1, indicating that its stock price is 110% more volatile than the S&P 500. Does the media favor BLFS or ZIMV? In the previous week, BioLife Solutions had 9 more articles in the media than ZimVie. MarketBeat recorded 10 mentions for BioLife Solutions and 1 mentions for ZimVie. ZimVie's average media sentiment score of 1.67 beat BioLife Solutions' score of 0.34 indicating that ZimVie is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioLife Solutions 2 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ZimVie 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummaryBioLife Solutions and ZimVie tied by winning 9 of the 18 factors compared between the two stocks. Remove Ads Get ZimVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ZIMV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZIMV vs. The Competition Export to ExcelMetricZimVieDental equipment & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$273.46M$3.35B$5.53B$7.50BDividend YieldN/A2.16%4.87%4.05%P/E Ratio-0.7533.0623.1618.08Price / Sales0.611.28356.5786.83Price / Cash2.776.5738.1634.64Price / Book0.640.626.483.99Net Income-$393.28M-$146.24M$3.21B$247.18M7 Day Performance-9.99%-11.02%-4.96%-4.25%1 Month Performance-26.99%-19.11%-0.13%-6.87%1 Year Performance-41.96%-37.15%6.26%-3.73% ZimVie Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZIMVZimVie2.2727 of 5 stars$9.54-2.9%$23.00+141.1%-43.6%$266.91M$449.75M-0.732,700Positive NewsBLFSBioLife Solutions1.703 of 5 stars$26.41+5.7%$29.86+13.1%+29.6%$1.24B$82.25M-24.92440Insider TradeNews CoveragePositive NewsGap DownKMTSKestra Medical TechnologiesN/A$24.50-1.8%N/AN/A$1.21B$45.82M0.00300MDXGMiMedx Group3.0614 of 5 stars$8.10+2.0%$12.00+48.1%+4.3%$1.19B$348.88M14.73870Positive NewsESTAEstablishment Labs2.277 of 5 stars$41.22+3.9%$57.40+39.3%-35.9%$1.19B$166.03M-15.98960FNAParagon 281.3199 of 5 stars$13.02+0.0%$14.20+9.1%+8.3%$1.09B$256.18M-17.59343,000High Trading VolumeEYENational Vision1.866 of 5 stars$13.61+4.5%$14.00+2.9%-45.1%$1.07B$1.82B-68.0514,000Short Interest ↑AORTArtivion3.3148 of 5 stars$24.99+2.3%$31.40+25.7%+13.1%$1.05B$388.54M-1,249.251,300Positive NewsGap DownRXSTRxSight3.1507 of 5 stars$24.92+0.3%$49.33+98.0%-68.4%$1.01B$139.93M-30.02220Analyst ForecastNews CoverageGap DownPLSEPulse Biosciences1.0456 of 5 stars$16.07+0.1%N/A+83.0%$988.58M$700,000.000.00140Gap UpAXGNAxoGen3.4859 of 5 stars$18.15+2.4%$22.60+24.5%+111.4%$804.84M$187.34M-56.72450Short Interest ↓Analyst Revision Remove Ads Related Companies and Tools Related Companies BioLife Solutions Competitors Kestra Medical Technologies Competitors MiMedx Group Competitors Establishment Labs Competitors Paragon 28 Competitors National Vision Competitors Artivion Competitors RxSight Competitors Pulse Biosciences Competitors AxoGen Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ZIMV) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZimVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZimVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
